Clinical trial
Reoxygenation After Cardiac Arrest (REOX Study)
NCT01881243 is registered in ClinicalTrials.gov with The Cooper Health System as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reoxygenation After Cardiac Arrest (REOX Study)
- Lead sponsor
- The Cooper Health System
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2013
- Completion date
- June 30, 2017
- Enrollment
- 280 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac arrest